A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm Giovanni PaganelliLisa BodeiIrvin Modlin Editorial 20 June 2020 Pages: 2223 - 2226
Metastatic melanoma: can FDG-PET predict success of anti-PD-1 therapy and help determine when it can be discontinued? Elif Hindié Editorial 22 April 2020 Pages: 2227 - 2232
Anatomy of 18F-GE180, a failed radioligand for the TSPO protein Paolo Zanotti-FregonaraBelen PascualFederico Turkheimer Letter to the Editor 22 February 2020 Pages: 2233 - 2236
In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein Nathalie L. AlbertM. UnterrainerP. Bartenstein Letter to the Editor Open access 10 June 2020 Pages: 2237 - 2241
18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis Richard NicholasDavid BrooksDavid Owen Letter to the Editor 08 May 2020 Pages: 2242 - 2243
The added benefit of contrast-enhanced CT in evaluation of incidental FDG-avid colon lesions Joseph C. LeeGemma F. HartnettAravind S. Ravi Kumar Letter to the Editor 12 February 2020 Pages: 2244 - 2244
Reply to Letter to the Editor: “The added benefit of contrast-enhanced CT in the evaluation of incidental FDG-avid colon lesions” Julian KirchnerBenedikt M. SchaarschmidtPhilipp Heusch Letter To The Editor & Reply Open access 30 June 2020 Pages: 2245 - 2246
Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial Shintaro AkiyamaCindy TraboulsiDavid T. Rubin Letter to the Editor 02 April 2020 Pages: 2247 - 2247
CTumorGAN: a unified framework for automatic computed tomography tumor segmentation Shuchao PangAnan DuGuanfeng Liu Original Article 28 March 2020 Pages: 2248 - 2268
Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracers Hong GrafeMaike E. LindemannHarald H. Quick Original Article Open access 03 March 2020 Pages: 2269 - 2279
Dynamic PET/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients Xiaoxia XuHua ZhuZhi Yang Original Article 12 March 2020 Pages: 2280 - 2292
Dynamic whole-body 18F-FDG PET for differentiating abnormal lesions from physiological uptake Motoki NishimuraNagara TamakiKei Yamada Original Article 18 March 2020 Pages: 2293 - 2300
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4 Romain-David SebanAntoine Moya-PlanaLaurent Dercle Original Article 23 March 2020 Pages: 2301 - 2312
Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach Susann-Cathrin OlthofAndrea ForschnerChristina Pfannenberg Original Article 02 March 2020 Pages: 2313 - 2321
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617 Justin FerdinandusJohn VioletMichael S. Hofman Short Communication 05 March 2020 Pages: 2322 - 2327
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy Marco M. E. VogelStephanie G. C. KroezeStephanie E. Combs Original Article Open access 16 March 2020 Pages: 2328 - 2338
Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy Jonathan MikschDirk BottkeVikas Prasad Original Article Open access 10 March 2020 Pages: 2339 - 2347
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma Jennifer E. GainsVeronica MorozMark N. Gaze Original Article 11 March 2020 Pages: 2348 - 2357
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice Vikas PrasadRaj SrirajaskanthanLisa Bodei Original Article Open access 15 February 2020 Pages: 2358 - 2371
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study Jonathan StrosbergPamela L. Kunzon behalf of the NETTER-1 study group Original Article Open access 02 March 2020 Pages: 2372 - 2382
Deep learning-based attenuation map generation for myocardial perfusion SPECT Luyao ShiJohn A. OnofreyChi Liu Original Article 26 March 2020 Pages: 2383 - 2395
Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value Nathan MalkaMukedaisi AbuliziThibaud Damy Original Article 10 March 2020 Pages: 2396 - 2406
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort Patrik FazioDaniel FerreiraAndrea Varrone Original Article Open access 04 February 2020 Pages: 2407 - 2416
Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT1A PET Mala AnanthElizabeth A. BartlettChuan Huang Original Article 13 February 2020 Pages: 2417 - 2428
PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511 Ryosuke ArakawaAkihiro TakanoAndrea Varrone Original Article Open access 06 March 2020 Pages: 2429 - 2439
Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer’s disease Shaozhen YanChaojie ZhengJie Lu Original Article Open access 10 March 2020 Pages: 2440 - 2452
Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series Nina CobesMohamed GuernouJean-François Grellier Short Communication 18 June 2020 Pages: 2453 - 2460
Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity Claire E. OwenAurora M. T. PoonRussell R. C. Buchanan Original Article 23 February 2020 Pages: 2461 - 2468
Lymphangioleiomyomatosis revealed by 68Ga-NOTA-Evans Blue PET/CT Guozhu HouWenshuai XuWuying Cheng Image of the Month 10 January 2020 Pages: 2469 - 2470
Tuberous sclerosis complex (TSC) with epilepsy on 18F-FDG simultaneous PET/MR Siwei LiuYang CaiHongcheng Shi Image of the Month 17 January 2020 Pages: 2471 - 2472
Segmental complex regional pain syndrome of the thumb Malik JuweidSalem AlYasjeenAws Kanfar Image of the Month 28 January 2020 Pages: 2473 - 2475
COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT Laura OlivariNiccolò RiccardiMatteo Salgarello Image of the Month 04 June 2020 Pages: 2476 - 2477
PET/MR and PET/CT in a severe COVID-19 patient Xiaochen LiYan WangMeiyun Wang Image of the Month 04 June 2020 Pages: 2478 - 2479
Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes Jun Pyo KimJeonghun KimJoon-Kyung Seong Correction 27 June 2020 Pages: 2480 - 2480
Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer E. J. van HeldenS. G. EliasC. W. Menke-van der Houven van Oordt Correction 13 June 2020 Pages: 2481 - 2481